Skip to main content

Telix Pharmaceuticals Ltd (TLX.AU) Share Price and Company Information, 2024

Telix Pharmaceuticals Ltd

TLX.AU

Exchange: AU
Currency Australian Dollar
Open Figi: BBG00HZHXWM5
ISIN: AU000000TLX2
Primary Ticker: TLX.AU
Fiscal Year End: December
International Domestic: International
Sector: Healthcare
Industry: Biotechnology
Gic Sector: Health Care
Gic Group: Pharmaceuticals, Biotechnology & Life Sciences
Gic Industry: Biotechnology
Gic Sub Industry: Biotechnology
Description: Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of diagnostic and therapeutic radiopharmaceuticals and related medical devices for cancer and rare diseases in Australia, Belgium, Japan, Switzerland, and the United States. Its lead products include TLX591-C Dx for the diagnosis and treatment of metastatic castrate-resistant prostate cancer; TLX250-C Dx that is in Phase III clinical trials for the treatment and diagnosis of renal (kidney) cancer; TLX101-C Dx for the diagnosis and treatment of glioblastoma (brain cancer); TLX66-C Dx to treat bone marrow conditioning and rare diseases; TLX300-C Dx for the treatment and diagnosis of soft tissue sarcoma; TLX250, which is in Phase II clinical trials for the diagnosis and treatment of kidney cancer; TLX591, which is in Phase III clinical trials for the diagnosis and treatment of metastatic castrate-resistant prostate cancer; TLX101 that is in Phase II clinical trials for the treatment of glioblastoma (brain cancer); TLX66, which is in Phase II clinical trials for the treatment of bone marrow conditioning and rare diseases; and TLX300 that is in Phase I clinical trial for the treatment and diagnosis of soft tissue sarcoma. The company also develops TLX592, a prostate cancer therapy candidate for targeted alpha therapy; and TLX599-C Dx for treatment of prostate cancer imaging agent. The company was founded in 2015 and is headquartered in North Melbourne, Australia.
Address: 55 Flemington Road, North Melbourne, VIC, Australia, 3051
Website: https://telixpharma.com
Updated On: 2024-04-06

Highlights

Market Capitalization: 4036915712
Market Capitalization Mln: 4036.91
EBITDA: 57173000
PE Ratio: 623
Wall Street Target Price: 14.88
Book Value: 0.46
Earnings Share: 0.02
EPS Estimate Current Year: 0.13
EPS Estimate Next Year: 0.28
Most Recent Quarter: 2023-12-31
Profit Margin: 0.01
Operating Margin TTM: 0.07
Return On Assets TTM: 0.09
Return On Equity TTM: 0.04
Revenue TTM: 502547008
Revenue Per Share TTM: 1.57
Quarterly Revenue Growth YOY: 1.07
Gross Profit TTM: 98540000
Diluted Eps TTM: 0.02

Valuation

Trailing PE: 623
Forward PE: 60.97
Price Sales TTM: 8.03
Price Book MRQ: 27.10
Enterprise Value: 3931122739
Enterprise Value Revenue: 7.91
Enterprise Value Ebitda: 171.17

Technicals

Beta: 2.34
52 Week High: 13.54
52 Week Low: 7.26
50 Day MA: 11.87
200 Day MA: 10.72

Holders

Name: SPDR Portfolio Developed World ex-US ETF
Date: 2021-02-28
Total Shares: 0.04
Current Shares: 10178
Name: SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF
Date: 2021-02-28
Total Shares: 0.02
Current Shares: 9723

Earnings

Report Date: 2025-02-20
Date: 2024-12-31
Before After Market: After Market
Currency: AUD
Report Date: 2024-08-21
Date: 2024-06-30
Before After Market: After Market
Currency: AUD
Report Date: 2024-04-15
Date: 2024-03-31
Currency: AUD
Report Date: 2023-10-18
Date: 2023-09-30
Currency: AUD
Report Date: 2023-08-23
Date: 2023-06-30
Before After Market: After Market
Currency: AUD
Eps Estimate: -0.00
Surprise Percent: 10
Report Date: 2023-04-17
Date: 2023-03-31
Before After Market: After Market
Currency: AUD
Report Date: 2023-02-27
Date: 2022-12-31
Before After Market: After Market
Currency: AUD
Eps Actual: -0.07
Eps Estimate: -0.00
Eps Difference: -0.06
Surprise Percent: -690
Report Date: 2022-10-20
Date: 2022-09-30
Before After Market: Before Market
Currency: AUD
Report Date: 2022-08-17
Date: 2022-06-30
Before After Market: After Market
Currency: AUD
Eps Actual: -0.23
Eps Estimate: -0.00
Eps Difference: -0.22
Surprise Percent: -20809.09
Report Date: 2022-06-01
Date: 2022-03-31
Currency: AUD
Report Date: 2022-02-24
Date: 2021-12-31
Before After Market: Before Market
Currency: AUD
Eps Actual: -0.17
Eps Estimate: -0.07
Eps Difference: -0.09
Surprise Percent: -120.77
Report Date: 2021-08-19
Date: 2021-06-30
Currency: AUD
Eps Actual: -0.12
Eps Estimate: -0.09
Eps Difference: -0.02
Surprise Percent: -23.07
Report Date: 2021-02-25
Date: 2020-12-31
Currency: AUD
Eps Actual: -0.1
Eps Difference: -0.1
Report Date: 2020-08-20
Date: 2020-06-30
Currency: AUD
Eps Actual: -0.07
Eps Difference: -0.07
Report Date: 2020-02-23
Date: 2019-12-31
Currency: AUD
Eps Actual: -0.07
Eps Difference: -0.07
Report Date: 2019-08-22
Date: 2019-06-30
Currency: AUD
Eps Actual: -0.05
Eps Difference: -0.05
Report Date: 2019-02-25
Date: 2018-12-31
Currency: AUD
Eps Actual: -0.04
Eps Difference: -0.04
Report Date: 2018-11-28
Date: 2018-09-30
Currency: AUD
Eps Actual: -0.06
Eps Estimate: -0.00
Eps Difference: -0.05
Surprise Percent: -990
Report Date: 2018-08-31
Date: 2018-06-30
Currency: AUD
Eps Actual: -0.03
Eps Difference: -0.03
Report Date: 2018-02-26
Date: 2017-12-31
Currency: AUD
Eps Actual: -0.08
Eps Difference: -0.08
Report Date: 2017-11-14
Date: 2017-09-30
Currency: AUD
Eps Actual: -0.01
Eps Difference: -0.01
Date: 2025-12-31
Period: +1y
Growth: 1.15
Earnings Estimate Avg: 0.28
Earnings Estimate Low: -0.02
Earnings Estimate High: 0.51
Earnings Estimate Year Ago Eps: 0.13
Earnings Estimate Number Of Analysts: 8.00
Earnings Estimate Growth: 1.15
Revenue Estimate Avg: 874530000.00
Revenue Estimate Low: 775200000.00
Revenue Estimate High: 1012260000.00
Revenue Estimate Number Of Analysts: 8.00
Revenue Estimate Growth: 0.24
Eps Trend Current: 0.28
Eps Trend7days Ago: 0.28
Eps Trend30days Ago: 0.28
Eps Trend60days Ago: 0.38
Eps Trend90days Ago: 0.41
Date: 2024-12-31
Growth: 5.50
Earnings Estimate Avg: 0.13
Earnings Estimate Low: -0.07
Earnings Estimate High: 0.23
Earnings Estimate Year Ago Eps: 0.02
Earnings Estimate Number Of Analysts: 7.00
Earnings Estimate Growth: 5.50
Revenue Estimate Avg: 700040000.00
Revenue Estimate Low: 686060000.00
Revenue Estimate High: 717300000.00
Revenue Estimate Number Of Analysts: 8.00
Revenue Estimate Growth: 0.39
Eps Trend Current: 0.13
Eps Trend7days Ago: 0.13
Eps Trend30days Ago: 0.13
Eps Trend60days Ago: 0.31
Eps Trend90days Ago: 0.30
Date: 2024-03-31
Period: +1q
Date: 2023-12-31
Growth: 1.11
Earnings Estimate Avg: 0.04
Earnings Estimate Low: 0.01
Earnings Estimate High: 0.06
Earnings Estimate Year Ago Eps: -0.34
Earnings Estimate Number Of Analysts: 6.00
Earnings Estimate Growth: 1.11
Revenue Estimate Avg: 501870000.00
Revenue Estimate Low: 495400000.00
Revenue Estimate High: 508200000.00
Revenue Estimate Number Of Analysts: 8.00
Revenue Estimate Growth: 2.13
Eps Trend Current: 0.04
Eps Trend7days Ago: 0.04
Eps Trend30days Ago: 0.05
Eps Trend60days Ago: 0.05
Eps Trend90days Ago: 0.04
Date: 2023-09-30
Date: 2023-06-30
Date: 2023-03-31
Date: 2022-12-31
Growth: 0.07
Earnings Estimate Avg: -0.26
Earnings Estimate Low: -0.30
Earnings Estimate High: -0.23
Earnings Estimate Year Ago Eps: -0.28
Earnings Estimate Number Of Analysts: 6.00
Earnings Estimate Growth: 0.07
Revenue Estimate Avg: 154630000.00
Revenue Estimate Low: 146100000.00
Revenue Estimate High: 157550000.00
Revenue Estimate Number Of Analysts: 6.00
Revenue Estimate Growth: 19.35
Eps Trend Current: -0.26
Eps Trend7days Ago: -0.26
Eps Trend30days Ago: -0.26
Eps Trend60days Ago: -0.24
Eps Trend90days Ago: -0.25
Date: 2022-09-30
Date: 2022-06-30
Date: 2022-03-31
Period: +1q
Date: 2021-12-31
Revenue Estimate Avg: 106750000.00
Revenue Estimate Low: 82800000.00
Revenue Estimate High: 128090000.00
Revenue Estimate Number Of Analysts: 6.00
Revenue Estimate Growth: 13.05
Date: 2019-12-31
Period: +1y
Revenue Estimate Avg: 4990000.00
Revenue Estimate Low: 1600000.00
Revenue Estimate High: 8380000.00
Revenue Estimate Number Of Analysts: 2.00
Revenue Estimate Growth: 0.90
Eps Trend7days Ago: -0.09
Eps Trend30days Ago: -0.09
Eps Trend60days Ago: -0.09
Eps Trend90days Ago: -0.09
Date: 2019-06-30
Period: +1q
Revenue Estimate Avg: 2620000.00
Revenue Estimate Low: 230000.00
Revenue Estimate High: 5000000.00
Revenue Estimate Number Of Analysts: 2.00
Date: 2019-03-31
Revenue Estimate Avg: 2620000.00
Revenue Estimate Low: 230000.00
Revenue Estimate High: 5000000.00
Revenue Estimate Number Of Analysts: 2.00
Date: 2018-12-31
Revenue Estimate Avg: 2620000.00
Revenue Estimate Low: 230000.00
Revenue Estimate High: 5000000.00
Revenue Estimate Number Of Analysts: 2.00
Eps Trend7days Ago: -0.06
Eps Trend30days Ago: -0.06
Eps Trend60days Ago: -0.06
Eps Trend90days Ago: -0.06
Date: 2024-03-31
Date: 2022-12-31
Eps Actual: -0.
Date: 2021-12-31
Eps Actual: -0.2
Date: 2020-12-31
Eps Actual: -0.1
Date: 2019-12-31
Eps Actual: -0.1
Date: 2018-12-31
Eps Actual: -0.1
Date: 2017-12-31
Eps Actual: -0.0